Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers
Crossref DOI link: https://doi.org/10.1007/s13238-019-0640-1
Published Online: 2019-06-12
Published Print: 2019-12-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ge, Yuanlong
Wu, Shu
Zhang, Zepeng
Li, Xiaocui
Li, Feng
Yan, Siyu
Liu, Haiying
Huang, Junjiu
Zhao, Yong
Version of Record valid from 2023-02-15
Text and Data Mining valid from 2019-06-12
Version of Record valid from 2019-06-12
Article History
First Online: 12 June 2019